{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:07:41Z","timestamp":1790845661896,"version":"4.1.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014592","name":"Insulet Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The use of automated insulin delivery systems (AID) is standard of care for people with type 1 diabetes. However, the limited capacity of insulin pump cartridges, which can hold 1.6-3.0mL or the equivalent of 160\u2013300 units of U100 insulin, can be a barrier to AID use for individuals with high total daily insulin (TDI) requirements. With the rising prevalence of obesity, expansion of AID use to type 2 diabetes, and trends towards smaller cartridge volumes to decrease the size of devices, practical solutions to reduce barriers to AID use for those with high TDI requirements are needed. U200 concentrated rapid-acting insulin (U200) has a similar pharmacokinetic and pharmacodynamic profile to U100 insulin, provides the same dose of U100 insulin in half of the volume, and has been used off-label to facilitate AID use for those with high TDI needs. In this perspective piece we provide practical considerations for clinical implementation of U200 use in AID systems, including identification of candidates, unique considerations in filling pumps with U200 insulin, guidance on programming appropriate AID settings for the different algorithms, concepts to address in patient education, and recommendations for standardized documentation in the electronic health record.<\/jats:p>","DOI":"10.3389\/fendo.2025.1692589","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:18:09Z","timestamp":1761628689000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Practical considerations for using concentrated U200 insulin in automated insulin delivery systems"],"prefix":"10.3389","volume":"16","author":[{"given":"Brynn E.","family":"Marks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Y.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Parimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa M.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cari","family":"Berget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S007","article-title":"7. Diabetes technology: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000543034","article-title":"ISPAD clinical practice consensus guidelines 2024: diabetes technologies: insulin delivery","author":"Biester","year":"2024","journal-title":"Horm Res Paediatr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2415948","article-title":"A randomized trial of automated insulin delivery in type 2 diabetes","volume":"392","author":"Kudva","year":"2025","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.59348","article-title":"Automated insulin delivery in adults with type 2 diabetes: A nonrandomized clinical trial","volume":"8","author":"Pasquel","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-022-05744-z","article-title":"Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association","volume":"66","author":"Sherr","year":"2023","journal-title":"Diabetologia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1089\/152091502320798312","article-title":"Variability of insulin absorption and insulin action","volume":"4","author":"Heinemann","year":"2002","journal-title":"Diabetes Technol Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1319","article-title":"Enhanced absorption of insulin aspart as the result of a dispersed injection strategy tested in a randomized trial in type 1 diabetic patients","volume":"36","author":"Mader","year":"2013","journal-title":"Diabetes Care"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.622901","article-title":"Nutrition and obesity in the pathogenesis of youth-onset type 1 diabetes and its complications","volume":"12","author":"March","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.01.008","article-title":"Prevalence and clinical determinants of obesity in adults with type 1 diabetes mellitus: A single-center retrospective observational study","volume":"28","author":"Tsushima","year":"2022","journal-title":"Endocr Pract"},{"key":"B10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/cpdd.221","article-title":"Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U\/mL relative to insulin lispro (Humalog(R)) 100 U\/mL","volume":"5","author":"de la Pena","year":"2016","journal-title":"Clin Pharmacol Drug Dev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"10.1177\/15209156251359167","DOI":"10.1177\/15209156251359167","article-title":"Real-world safety and effectiveness of U200 insulin use in automated insulin delivery systems in adolescents and young adults with type 1 diabetes","volume":"18","author":"Chu","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"B12","volume-title":"PA: Institute for Safe Medication Practices","year":"2017"},{"key":"B13","volume-title":"Applying Human Factors and Usability Engineering to Medical Devices: Guidance for Industry and Food and Drug Administration Staff","year":"2016"},{"key":"B14","year":"2014"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0376","article-title":"Accuracy of bolus and basal rate delivery of different insulin pump systems","volume":"21","author":"Freckmann","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12993","article-title":"Accuracy assessment of bolus and basal rate delivery of different insulin pump systems used in insulin pump therapy of children and adolescents","volume":"21","author":"Ziegler","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/diaspect.29.3.140","article-title":"Embracing the insulin revolution in the ambulatory care setting","volume":"29","author":"Bzowyckyj","year":"2016","journal-title":"Diabetes Spectr"},{"key":"B18","year":"2025"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0509","article-title":"Cost, hassle, and on-body experience: barriers to diabetes device use in adolescents and potential intervention targets","volume":"22","author":"Messer","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1536","article-title":"Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential intervention targets","volume":"40","author":"Tanenbaum","year":"2017","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1555265","article-title":"Can I afford to live today?\" The emotional toll of navigating the healthcare system with type 1 diabetes","volume":"16","author":"Harel","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4158\/EP10014.OR","article-title":"A prospective trial of U500 insulin delivered by Omnipod in patients with type 2 diabetes mellitus and severe insulin resistance","volume":"16","author":"Lane","year":"2010","journal-title":"Endocr Pract"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP-2019-0607","article-title":"Concentrated insulins: clinical update of therapeutic options","volume":"26","author":"Umpierrez","year":"2020","journal-title":"Endocr Pract"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0721","article-title":"Pharmacokinetics and pharmacodynamics of high-dose human regular U-500 insulin versus human regular U-100 insulin in healthy obese subjects","volume":"34","author":"de la Pena","year":"2011","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-1054","article-title":"Pharmacokinetics and pharmacodynamics of a novel U500 insulin aspart formulation: A randomized, double-blind, crossover study in people with type 1 diabetes","volume":"46","author":"Svehlikova","year":"2023","journal-title":"Diabetes Care"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1692589\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:18:10Z","timestamp":1761628690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1692589\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":26,"alternative-id":["10.3389\/fendo.2025.1692589"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1692589","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"article-number":"1692589"}}